Dear Healthcare Provider,
The information contained here may be very important to your practice. Please take a moment to review this document.
Prenatal Risk Assessment Testing
QUAD screens and Maternal Serum AFP
January 4, 2021
Effective January 4, 2021, Alverno Laboratories will begin sending QUAD screens and Maternal Serum AFP prenatal risk
assessment testing to ARUP Laboratories. The quality of our risk assessment algorithms is dependent on robust statistical
data that requires a testing volume that we are no longer able to sustain.
To provide the most accurate analysis, detailed information regarding the patient history is required.
Please see page 2 for the Prenatal Risk Assessment Form. This form is readily available from our collection manual as well
as under the “Provider Forms” tab on the Alverno website. All questions must be answered for more accurate risk analysis.
Unanswered questions will delay testing.